- KR₩24bn
- KR₩36bn
- KR₩59bn
Announces Oled Display Equipment Supply Contract
Corrected: ANALYSIS-Hims' obesity drug business may get boost as employers drop coverage
Brief: Hims Co To Supply Oled Display Equipment To Chengdu Topway High Tech
Brief: Hims Co Ltd Wins 7.5 Billion Won Order
Novo Nordisk nominates Jan van de Winkel and Ramona Sequeira to board (updated)
Novo Nordisk nominates Jan van de Winkel and Ramona Sequeira to board
Analysis: US could take action including fines against Hims after brief Wegovy copy launch
Newscasts - Wall Street advances as tech bounces further off of recent losses
Analysis: Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
FDA to take action on companies marketing 'illegal copycat drugs', FDA chief says (updated)
Live Markets: Still bleeding
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Novo Nordisk falls after Reuters report of Hims launching Wegovy pill copy
Hims launches $49 compounded copy of Wegovy weight-loss pill (updated)
Hims and Hers Health launches compounded copy of Wegovy pill at $49
Hims and Hers Health launches copy of Wegovy pill at $49
Hims and Hers to offer weight-loss treatments in UK
Hims and Hers beats revenue estimates on strong subscriber growth (updated)